Bg pattern

PREGABALIN VIATRIS 150 mg HARD CAPSULES

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use PREGABALIN VIATRIS 150 mg HARD CAPSULES

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Pregabalin Mylan 25 mg hard capsules,

Pregabalin Mylan 50 mg hard capsules,

Pregabalin Mylan 75 mg hard capsules,

Pregabalin Mylan 100 mg hard capsules,

Pregabalin Mylan 150 mg hard capsules,

Pregabalin Mylan 200 mg hard capsules,

Pregabalin Mylan 225 mg hard capsules,

Pregabalin Mylan 300 mg hard capsules

pregabalin

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What Pregabalin Mylan is and what it is used for
  2. What you need to know before you take Pregabalin Mylan
  3. How to take Pregabalin Mylan
  4. Possible side effects
  5. Storage of Pregabalin Mylan
  6. Contents of the pack and other information

1. What Pregabalin Mylan is and what it is used for

Pregabalin Mylan contains the active substance pregabalin, which belongs to a group of medicines used to treat epilepsy, neuropathic pain, and generalized anxiety disorder (GAD) in adults.

Peripheral and central neuropathic pain: Pregabalin Mylan is used to treat long-standing pain caused by damage to the nerves. There are several diseases that can cause peripheral neuropathic pain, such as diabetes or shingles. The feeling of pain may be described as hot, burning, throbbing, shooting, stabbing, sharp, cramping, aching, heavy, or tender. Peripheral neuropathic pain may also be associated with mood changes, sleep disturbances, fatigue (tiredness), and can have an impact on physical and social functioning and overall quality of life.

Epilepsy: Pregabalin Mylan is used to treat certain types of epilepsy (partial seizures with or without secondary generalization) in adults. Your doctor will prescribe Pregabalin Mylan to treat epilepsy when your current treatment is not controlling your condition. You should take Pregabalin Mylan in addition to your current treatment. Pregabalin Mylan should not be taken alone but should always be used in combination with other anti-epileptic treatments.

Generalized anxiety disorder: Pregabalin Mylan is used to treat generalized anxiety disorder (GAD). The symptoms of GAD are prolonged and excessive worry and anxiety that are difficult to control. GAD can also cause restlessness or feeling on edge, being easily fatigued, having difficulty concentrating or making decisions, irritability, muscle tension, or sleep disturbances. This is different from the stress and anxiety of everyday life.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Pregabalin Mylan

Do not take Pregabalin Mylan

  • If you are allergic to pregabalin or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before taking Pregabalin Mylan.

  • Some patients taking Pregabalin Mylan have reported symptoms that suggest an allergic reaction. These symptoms include swelling of the face, lips, tongue, and throat, as well as a diffuse rash. If you experience any of these symptoms, you should contact your doctor immediately.
  • Pregabalin Mylan has been associated with dizziness and somnolence, which may increase the risk of accidental injury (falls) in elderly patients. Therefore, you should be cautious until you are used to the effects of this medicine.
  • Pregabalin Mylan may cause blurred vision, loss of vision, or other changes in vision, many of which are transient. If you experience any changes in your vision, you should inform your doctor immediately.
  • Diabetic patients who gain weight while taking pregabalin may need a dose adjustment of their diabetic medications.
  • Certain side effects, such as somnolence, may be more frequent because patients with spinal cord injury may be taking other medications for treatment, such as pain or spasticity, with similar side effects to those of Pregabalin Mylan, so the intensity of these effects may increase when taken together.
  • There have been reports of heart failure in some patients taking Pregabalin Mylan. Most of these patients were elderly with cardiovascular conditions. Before using this medicine, you should inform your doctor if you have a history of heart disease.
  • There have been reports of renal failure in some patients taking Pregabalin Mylan. If you notice a decrease in your ability to urinate during treatment with Pregabalin Mylan, you should inform your doctor, as stopping treatment may improve the situation.
  • A small number of people taking antiepileptics, such as Pregabalin Mylan, have had thoughts of harming themselves or committing suicide. If at any time you have these thoughts, contact your doctor as soon as possible.
  • When Pregabalin Mylan is taken with other medications that can cause constipation (such as some types of pain medications), gastrointestinal problems (e.g., constipation and intestinal blockage or paralysis) may occur. Inform your doctor if you experience constipation, especially if you are prone to this problem.
  • Before taking this medicine, you should inform your doctor if you have a history of alcoholism or abuse or dependence on any drug. Do not take a higher dose than prescribed.
  • There have been reports of seizures during treatment with Pregabalin Mylan or shortly after stopping treatment with Pregabalin Mylan. If you experience seizures, contact your doctor immediately.
  • There have been reports of reduced brain function (encephalopathy) in some patients taking Pregabalin Mylan who had other illnesses. Inform your doctor if you have a history of any serious illness, including liver or kidney disease.

Children and adolescents

The safety and efficacy in children and adolescents (under 18 years of age) have not been established, so pregabalin should not be used in this age group.

Using Pregabalin Mylan with other medicines

Inform your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Pregabalin Mylan and certain medicines may interact with each other (interactions). When Pregabalin Mylan is used with certain medicines, the adverse reactions seen with them may be increased, including respiratory failure and coma. The degree of dizziness, somnolence, and decreased concentration may increase if Pregabalin Mylan is taken with other medicines that contain:

  • Oxycodone - (used as a pain reliever)
  • Lorazepam - (used to treat anxiety)
  • Alcohol

Pregabalin Mylan can be taken with oral contraceptives.

Taking Pregabalin Mylan with food, drinks, and alcohol

Pregabalin Mylan capsules can be taken with or without food.

It is advised not to drink alcohol during treatment with Pregabalin Mylan.

Pregnancy and breastfeeding

Do not take Pregabalin Mylan during pregnancy or breastfeeding, unless your doctor has told you to do so. An effective contraceptive method should be used in women of childbearing age. If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Driving and using machines

Pregabalin Mylan may cause dizziness, somnolence, and decreased concentration. You should not drive, operate heavy machinery, or engage in other potentially hazardous activities until you know whether this medicine affects your ability to perform these activities.

3. How to take Pregabalin Mylan

Follow exactly the instructions given to you by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.

Your doctor will determine the dose that is right for you.

Pregabalin Mylan is for oral use only.

Peripheral and central neuropathic pain, epilepsy, or generalized anxiety disorder:

  • Take the number of capsules that your doctor has prescribed for you.
  • The dose, which has been adjusted for you and your condition, will generally be between 150 mg and 600 mg per day.
  • Your doctor will tell you to take Pregabalin Mylan either twice or three times a day. For twice-daily dosing, take Pregabalin Mylan once in the morning and once in the evening, approximately at the same time every day. For three-times-daily dosing, take Pregabalin Mylan in the morning, at noon, and in the evening, approximately at the same time every day.

If you think that the effect of Pregabalin Mylan is too strong or too weak, talk to your doctor or pharmacist.

If you are an elderly patient (over 65 years of age), you should take Pregabalin Mylan normally, except if you have kidney problems.

Your doctor may prescribe a different dosing regimen or dose if you have kidney problems.

Swallow the capsule whole with water.

Continue taking Pregabalin Mylan until your doctor tells you to stop.

If you take more Pregabalin Mylan than you should

Contact your doctor or the nearest hospital emergency department immediately. Take the pack or container with you. As a result of taking more Pregabalin Mylan than you should, you may feel drowsy, confused, agitated, or restless. Seizures have also been reported.

If you forget to take Pregabalin Mylan

It is important that you take your Pregabalin Mylan capsules regularly at the same time each day. If you forget to take a dose, take it as soon as you remember, unless it is time for your next dose. In this case, continue with your next dose as usual. Do not take a double dose to make up for a forgotten dose.

If you stop taking Pregabalin Mylan

Do not stop taking Pregabalin Mylan unless your doctor tells you to. If you are going to stop taking Pregabalin Mylan, this should be done gradually over a minimum of one week.

After stopping treatment with Pregabalin Mylan, either after a short or a long period of treatment, you may experience certain side effects. These include sleep disturbances, headache, nausea, feeling anxious, diarrhea, flu-like symptoms, seizures, nervousness, depression, pain, sweating, and dizziness. These symptoms may occur more frequently or be more severe if you have been taking Pregabalin Mylan for a longer period.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Very common: may affect more than 1 in 10 people

  • Dizziness, drowsiness, headache.

Common: may affect up to 1 in 10 people

  • Increased appetite.
  • Feeling of euphoria, confusion, disorientation, decreased sexual interest, irritability.
  • Disturbance in attention, clumsiness, impaired memory, memory loss, tremors, difficulty speaking, sensation of tingling, numbness, sedation, lethargy, insomnia, fatigue, abnormal sensation.
  • Blurred vision, double vision.
  • Dizziness, balance disorder, falls.
  • Dry mouth, constipation, vomiting, flatulence, diarrhea, nausea, abdominal distension.
  • Difficulty with erection.
  • Swelling of the body, including the limbs.
  • Feeling of intoxication, gait disturbances.
  • Weight gain.
  • Muscle cramp, joint pain, back pain, pain in the limbs.
  • Sore throat.

Uncommon: may affect up to 1 in 100 people

  • Loss of appetite, weight loss, low blood sugar, high blood sugar.
  • Change in perception of self, restlessness, depression, agitation, mood changes, difficulty finding words, hallucinations, unusual dreams, panic attacks, apathy, aggression, elevated mood, mental impairment, difficulty thinking, increased sexual interest, sexual dysfunction, including inability to reach climax, delayed ejaculation.
  • Changes in vision, unusual eye movements, changes in vision, including tunnel vision, flashes of light, spasmodic movements, decreased reflexes, hyperactivity, dizziness when standing up, sensitive skin, loss of taste, burning sensation, tremor when moving, decreased consciousness, loss of consciousness, fainting, increased sensitivity to noise, general malaise.
  • Dry eyes, swollen eyes, eye pain, tired eyes, watery eyes, eye irritation.
  • Abnormal heart rhythm, increased heart rate, low blood pressure, high blood pressure, changes in heart rhythm, heart failure.
  • Flushing, hot flushes.
  • Breathing difficulties, dry nose, nasal congestion.
  • Increased saliva production, heartburn, numbness around the mouth.
  • Sweating, rash, chills, fever.
  • Muscle spasms, swollen joints, muscle stiffness, pain, including muscle pain, neck pain.
  • Breast pain.
  • Difficulty or pain when urinating, inability to control urination.
  • Weakness, thirst, chest tightness.
  • Changes in blood and liver test results (elevated creatine phosphokinase in blood, elevated alanine aminotransferase, elevated aspartate aminotransferase, decreased platelet count, neutropenia, elevated creatinine in blood, decreased potassium in blood).
  • Hypersensitivity, swelling of the face, itching, hives, runny nose, nosebleeds, coughing, wheezing.
  • Painful menstrual periods.
  • Feeling of cold in hands and feet.

Rare: may affect up to 1 in 1,000 people

  • Altered sense of smell, wavering vision, altered depth perception, visual glare, loss of vision.
  • Dilated pupils, crossed eyes.
  • Cold sweats, throat tightness, swollen tongue.
  • Pancreatitis.
  • Difficulty swallowing.
  • Slow or reduced body movement.
  • Difficulty writing correctly.
  • Fluid accumulation in the abdominal area.
  • Fluid in the lungs.
  • Seizures.
  • Changes in the electrocardiogram (ECG) corresponding to heart rhythm disturbances.
  • Muscle damage.
  • Milk secretion, abnormal breast growth, breast enlargement in men.
  • Disruption of menstrual periods.
  • Kidney failure, decreased urine output, urinary retention.
  • Decreased white blood cell count.
  • Inappropriate behavior.
  • Allergic reactions (which may include difficulty breathing, eye inflammation (keratitis), and a severe skin reaction characterized by rash, blisters, peeling of the skin, and pain).
  • Jaundice (yellowing of the skin and eyes).

Very rare: may affect up to 1 in 10,000 people

  • Liver failure.
  • Hepatitis (inflammation of the liver).

If you experience swelling of the face or tongue, or if your skin turns red and develops blisters or peels, you should seek medical attention immediately.

Certain side effects, such as somnolence, may be more frequent because patients with spinal cord injury may be taking other medications for treatment, such as pain or spasticity, with similar side effects to those of Pregabalin Mylan, so the intensity of these effects may increase when taken together.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Pregabalin Mylan

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of the month shown.

Blister:Store in the original package to protect from moisture.

Bottle:Keep the bottle tightly closed to protect from moisture.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Container contents and additional information

Composition of Pregabalina Mylan

The active ingredient is pregabalin. Each hard capsule contains 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg or 300 mg of pregabalin.

The other ingredients are: hydroxypropylcellulose, corn starch, talc, gelatin, titanium dioxide (E171), sodium lauryl sulfate, black ink (containing Shellac lacquer, black iron oxide (E172), macrogol, potassium hydroxide and concentrated ammonia solution), yellow iron oxide (E172) and erythrosine (E127).

Appearance of Pregabalina Mylan and container contents

Hard capsule.

Hard white or off-white capsules with axial printing MYLAN and dose in black ink, presented in perforated blisters or bottles

Hard capsules of Pregabalina Mylan 200, 225 and 300 mg in blisters, with text indicating quantity per container and capsule coloration

Only some pack sizes may be marketed.

Marketing authorization holder

Mylan S.A.S

117 Allée des Parcs

69800 Saint-Priest

France

Manufacturer

Mylan Hungary Kft, Mylan utca 1, Komárom, 2900, Hungary

McDermott Laboratories Limited trading as Gerard Laboratories, 35/36 Baldoyle Industrial Estate, Grange Road, Dublin 13, Ireland

Mylan B.V., Dieselweg 25, 3752 LB Bunschoten, Netherlands

Logiters, Logistica, Portugal, S.A., Estrada dos Arneiros, 4, Azambuja, 2050-544, Portugal

For further information about this medicinal product, please contact the local representative of the marketing authorization holder.

België/Belgique/Belgien

Mylan bvba/sprl

Tel: + 32 (0)2 658 61 00

Lietuva

BGP Products UAB

Tel: +370 5 205 1288

България

БГП Продактс ЕООД

Тел: +359 2 44 55 400

Luxembourg/Luxemburg

Mylan bvba/sprl

Tel: + 32 (0)2 658 61 00

(Belgique/Belgien)

Česká republika

Mylan Pharmaceuticals s.r.o.

Tel: +420 222 004 400

Magyarország

Mylan EPD Kft

Tel: + 36 1 465 2100

Danmark

Mylan AB

Tlf: + 46 855 522 750

(Sverige)

Malta

V.J. Salomone Pharma Ltd.

Tel: + 356 21 22 01 74

Deutschland

Mylan dura GmbH

Tel: + 49-(0) 6172 888 01

Nederland

Mylan BV

Tel: + 31 (0)20 426 3300

Ελλάδα

Generics Pharma Hellas ΕΠΕ

Τηλ: +30 210 993 6410

Österreich

Arcana Arzneimittel GmbH

Tel: +43 1 416 2418

España

Mylan Pharmaceuticals, S.L

Tel: + 34 900 102 712

Polska

Mylan Healthcare Sp. z.o.o.

Tel: + 48 22 546 64 00

France

Mylan S.A.S

Tel: +33 4 37 25 75 00

Portugal

Mylan, Lda.

Tel: + 351 21 412 72 56

Hrvatska

Mylan Hrvatska d.o.o.

Tel: +385 1 23 50 599

România

BGP Products SRL

Tel: +40 372 579 000

Ireland

Mylan Ireland

Tel: +353 (0) 87 1694982

Slovenija

GSP Proizvodi d.o.o.

Tel: + 386 1 236 31 85

Ísland

Mylan AB

Tel: + 46 855 522 750

(Svíþjóð)

Slovenská republika

Mylan s.r.o.

Tel: +421 2 32 199 100

Italia

Mylan S.p.A

Tel: + 39 02 612 46921

Suomi/Finland

Mylan OY

Puh/Tel: + 358 20 720 9555

Κύπρος

Pharmaceutical Trading Co. Ltd.

Τηλ: + 357 99403969

Sverige

Mylan AB

Tel: + 46 855 522 750

Latvija

BGP Products SIA

Tel: +371 676 055 80

United Kingdom

Generics [UK] Ltd

Tel: +44 1707 853000

Date of last revision of this leaflet

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu.

Online doctors for PREGABALIN VIATRIS 150 mg HARD CAPSULES

Discuss questions about PREGABALIN VIATRIS 150 mg HARD CAPSULES, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for PREGABALIN VIATRIS 150 mg HARD CAPSULES?
PREGABALIN VIATRIS 150 mg HARD CAPSULES requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in PREGABALIN VIATRIS 150 mg HARD CAPSULES?
The active ingredient in PREGABALIN VIATRIS 150 mg HARD CAPSULES is pregabalin. This information helps identify medicines with the same composition but different brand names.
How much does PREGABALIN VIATRIS 150 mg HARD CAPSULES cost in pharmacies?
The average pharmacy price for PREGABALIN VIATRIS 150 mg HARD CAPSULES is around 29.41 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures PREGABALIN VIATRIS 150 mg HARD CAPSULES?
PREGABALIN VIATRIS 150 mg HARD CAPSULES is manufactured by Viatris Limited. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of PREGABALIN VIATRIS 150 mg HARD CAPSULES online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether PREGABALIN VIATRIS 150 mg HARD CAPSULES is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to PREGABALIN VIATRIS 150 mg HARD CAPSULES?
Other medicines with the same active substance (pregabalin) include ACIRYL 150 mg HARD CAPSULES, ACIRYL 25 mg HARD CAPSULES, ACIRYL 300 mg HARD CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media